FDA Guides On Generic Development During COVID-19
Q&A Guidance Document Addresses Common Queries From ANDA Applicants
Guidance published by the US FDA in the form of a question-and-answer document addresses questions from ANDA applicants about generic drug development during the COVID-19 pandemic.
